Literature DB >> 25210060

Emerging viral diseases: confronting threats with new technologies.

Hilary D Marston1, Gregory K Folkers1, David M Morens1, Anthony S Fauci2.   

Abstract

Emerging viral diseases pose ongoing health threats, particularly in an era of globalization; however, new biomedical research technologies such as genome sequencing and structure-based vaccine and drug design have improved our ability to respond to viral threats.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh：

Year:  2014        PMID： 25210060     DOI： 10.1126/scitranslmed.3009872

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  41 in total

1.  Ebola Virus Disease: Rapid Diagnosis and Timely Case Reporting are Critical to the Early Response for Outbreak Control.

Authors:  Lola V Stamm
Journal:  Am J Trop Med Hyg       Date:  2015-07-14       Impact factor: 2.345

Review 2.  Screening out irrelevant cell-based models of disease.

Authors:  Peter Horvath; Nathalie Aulner; Marc Bickle; Anthony M Davies; Elaine Del Nery; Daniel Ebner; Maria C Montoya; Päivi Östling; Vilja Pietiäinen; Leo S Price; Spencer L Shorte; Gerardo Turcatti; Carina von Schantz; Neil O Carragher
Journal:  Nat Rev Drug Discov       Date:  2016-09-12       Impact factor: 84.694

3.  Existing Host Range Mutations Constrain Further Emergence of RNA Viruses.

Authors:  Lele Zhao; Mansha Seth-Pasricha; Dragoş Stemate; Alvin Crespo-Bellido; Jacqueline Gagnon; Jeremy Draghi; Siobain Duffy
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

4.  Chandipura Virus Utilizes the Prosurvival Function of RelA NF-κB for Its Propagation.

Authors:  Sachendra S Bais; Yashika Ratra; Naseem A Khan; Rakesh Pandey; Pramod K Kushawaha; Shailly Tomar; Guruprasad Medigeshi; Abhyudai Singh; Soumen Basak
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

5.  Is regulation preventing the development of therapeutics that may prevent future coronavirus pandemics?

Authors:  Timothy P Sheahan; Ralph S Baric
Journal:  Future Virol       Date:  2018-02-21       Impact factor: 1.831

6.  Effective in Vivo Targeting of Influenza Virus through a Cell-Penetrating/Fusion Inhibitor Tandem Peptide Anchored to the Plasma Membrane.

Authors:  T N Figueira; M T Augusto; K Rybkina; D Stelitano; M G Noval; O E Harder; A S Veiga; D Huey; C A Alabi; S Biswas; S Niewiesk; A Moscona; N C Santos; M A R B Castanho; M Porotto
Journal:  Bioconjug Chem       Date:  2018-09-14       Impact factor: 4.774

7.  Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated Virolysis.

Authors:  Hans Prochnow; Katharina Rox; N V Suryanarayana Birudukota; Loreen Weichert; Sven-Kevin Hotop; Philipp Klahn; Kathrin Mohr; Sergej Franz; Dominic H Banda; Sebastian Blockus; Janine Schreiber; Sibylle Haid; Merel Oeyen; Javier P Martinez; Roderich D Süssmuth; Joachim Wink; Andreas Meyerhans; Christine Goffinet; Martin Messerle; Thomas F Schulz; Andrea Kröger; Dominique Schols; Thomas Pietschmann; Mark Brönstrup
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

Review 8.  Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.

Authors:  Emrullah Korkmaz; Stephen C Balmert; Cara Donahue Carey; Geza Erdos; Louis D Falo
Journal:  Expert Opin Drug Deliv       Date:  2020-10-06       Impact factor: 8.129

Review 9.  Reservoir host immune responses to emerging zoonotic viruses.

Authors:  Judith N Mandl; Rafi Ahmed; Luis B Barreiro; Peter Daszak; Jonathan H Epstein; Herbert W Virgin; Mark B Feinberg
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

10.  Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers.

Authors:  David S Fedson; Jeffrey R Jacobson; Ole Martin Rordam; Steven M Opal
Journal:  MBio       Date:  2015-06-23       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.